Neuralstem Announces First Patient Treated in ALS Stem Cell Trial

January 21, 2010

Rockville, Md.-based Neuralstem, Inc. (CUR) said on January 21 that the first amyotrophic lateral sclerosis (ALS) patient was treated with its spinal cord stem cells at the Emory ALS Center at Emory University, in Atlanta, Ga.

Up to 18 patients are expected to be treated in this first U.S. clinical trial to evaluate human neural stem cells for the treatment of ALS, also known as Lou Gehrig’s disease.

ALS affects roughly 30,000 people in the U.S., with about 5,600 new diagnoses per year, according to the ALS Association.

To read the complete article, please click on the following link:

http://www.stemcellresearchnews.com/absolutenm/anmviewer.asp?a=1962&z=9

Advertisements

One Response to “Neuralstem Announces First Patient Treated in ALS Stem Cell Trial”

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: